Pfizer's Former Headquarters Crumbles Alongside Its Stock
Construction at Pfizer's former Manhattan headquarters halted Tuesday due to crumbling floors and structural issues. The building, sold eight years ago for apartment conversion, mirrors the stock's poor performance. Pfizer shares began Tuesday with the highest dividend yield in the S&P 500 at over 7%.
Key Numbers
Construction at Pfizer's (PFE) former headquarters in Manhattan was halted Tuesday due to crumbling floors and other structural issues, according to reports. The building, which the company sold about eight years ago for conversion to apartments, has become a metaphor for Pfizer stock, which began Tuesday with the highest yield in the S&P 500 at over 7%.
Details
The building in midtown Manhattan suffers from structural deterioration that led to a halt in construction. Issues include cracked floors and weak structures, raising safety concerns.
Context
Pfizer stock (PFE) rose 1.6% to $24.10 on Tuesday, but remains the worst performer among its large-cap U.S. pharma peers during 2026 and over the past 10 years. The high dividend yield reflects the stock's low price rather than strong dividend growth.
What This Means for Investors
The structural issues at the former headquarters do not directly impact Pfizer's current operations, but they serve as a reminder of the stock's poor performance and weak investor confidence. The high yield may attract income-seeking investors, but the historically weak performance warrants caution.
Frequently Asked Questions
Found this useful? Share it